← Back to all substances
C

metoprolol

251ms
Level 1

✓ What this shows

  • • Reported adverse events from FDA FAERS
  • • Descriptive statistics from a locked corpus
  • • Data verified with cryptographic hashes

✗ What this is NOT

  • • Not medical advice or recommendations
  • • Not proof of causality
  • • Not a complete safety profile

About this substance

1 INDICATIONS AND USAGE Metoprolol tartrate tablets are a beta-adrenergic blocker indicated for the treatment of: Hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. ( 1.1 ) Angina...

Known as: Metoprolol Tartrate
Route: ORAL
Source: OpenFDA Drug Labels · Reference only · Not medical advice
500
Events in Corpus
v20260131-01
315,332
Total in FDA
71%
Serious Reports
44
Fatal Outcomes

Seriousness

Serious
353
Non-Serious
147

Sex Distribution

Male
221
Female
257
Unknown
22

Age Distribution

0-17
2
18-40
8
41-64
150
65-84
217
85+
24
Unknown
99

Outcomes

Recovered/Resolved
338
Recovering/Resolving
85
Not Recovered/Not Resolved
280
Recovered with Sequelae
6
Fatal
44
Unknown
862

Top Reported Reactions (click to view reports)

Verification Data

Corpus Version: v20260131-01
Root Hash: ec5727564d1ed19be5b08b26d3866f446b12d3d388f5a8cd713332c6d97ad264
Stats Hash: N/A
EVE Decision ID: EVE-MED-20260402-7a01fd
ℹThis output reports adverse events from FDA FAERS. It does not constitute medical advice.

Molecular Structure (reference)

Structural visualization for identification only.

This visualization shows the molecular structure for identification purposes only. It does not represent pharmacological effect, safety, or clinical relevance.

Loading structure...